The rate of baseline CRP measurement was different between the 3 cohorts with 81% of patients from academic sites, 76% of patients from community sites, and 95% of patients from an IBD-focussed site having baseline values recorded (P-value < .001) (Table 3). Here, CRP is linked to inflammatory bowel disease.